Resources Contact Us Home
Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof

Image Number 5 for United States Patent #8101721.

The present invention is related to antibodies with binding affinity to fibroblast growth factor receptor 2 (FGFR2) optionally with binding affinity to other FGF receptors, which block both ligand-dependent and constitutive ligand independent receptor activation. Specifically, the present invention relates to antibodies with high affinity to more than one FGF receptor subtype, and fragments thereof, useful in treating disorders including cell proliferative diseases.

  Recently Added Patents
Method and system for remote delivery of email
Tablet computer
Method or system for investing and/or trading
Method for fabricating solar cell
Aggregating completion messages in a sideband interface
Wireless control system for a patient support apparatus
Chip on chip semiconductor device including an underfill layer having a resin containing an amine-based curing agent
  Randomly Featured Patents
Pneumatic launcher system
Cutlery set
Surface configuration of a vehicle, toy, and/or other replicas
Dust pan
Microporous material
Plastic cap for medicine container
Treatment of neoplastic disease with interleukin-10
Portable scanner
Integrated methods of performing network switch functions
Substituted extensively conjugated ionic polyacetylenes